Abstract
Prosthetic valve endocarditis (PVE) is a rare but serious complication of cardiac valve replacement surgery and is associated with high rates of morbidity and mortality. Despite significant advances in our understanding of the pathogenesis and management of this disease process, the rates of undesirable outcomes, including mortality directly attributable to infection, remain unacceptably high. The purpose of this article is to provide an up-to-date review of the changing epidemiology, microbiology and pathogenesis of PVE as well as review state-of-the-art diagnostic approaches and treatment for PVE, including the controversies surrounding the role of surgery for optimal management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
